- AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity2005 | 2. lékařská fakulta
- Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism2021 | Farmaceutická fakulta v Hradci Králové
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group2013 | Publikace bez příslušnosti k fakultě
- NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia2022 | 1. lékařská fakulta
- MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia2018 | Ústřední knihovna